Cancer frenemy pathways: Inducing immunogenic cell death by exploiting apoptosis-interferon antagonism with oncolytic viruses. [PDF]
Bozhdansky V, Bacharach E, Ehrlich M.
europepmc +1 more source
Dissecting residual disease in spheroids reveals pan-cancer persistence signatures and a therapeutic window for oncolytic viruses. [PDF]
Fauveau C +9 more
europepmc +1 more source
Oncolytic Viruses in Cancer Immunotherapy: From Molecular Engineering to Clinical Translation. [PDF]
Fayyad-Kazan M, Al-Tameemi S, Ouhtit A.
europepmc +1 more source
A Comprehensive Review of Modern Cancer Therapies Utilizing Oncolytic Viruses. [PDF]
Sułek M, Szuster-Ciesielska A.
europepmc +1 more source
Viral warriors: Unlocking the immune system's potential with oncolytic viruses in cancer immunotherapy. [PDF]
Ghavimi R +8 more
europepmc +1 more source
Oncolytic viruses: A novel therapeutic approach for pancreatic cancer. [PDF]
Esteves M, Matos AM, Cruz MT.
europepmc +1 more source
EGFRxCD16 bispecific antibodies orchestrate superior NK cell-mediated lysis of ovarian cancer and NSCLC cell lines in combination with oncolytic viruses. [PDF]
Gahbauer S, Poiret T.
europepmc +1 more source
Clinical prospects of oncolytic viruses: Key developments and challenges. [PDF]
Wang Z, Shen Y, Liang T.
europepmc +1 more source
Oncolytic Viruses in Glioblastoma: Clinical Progress, Mechanistic Insights, and Future Therapeutic Directions. [PDF]
Liu J +20 more
europepmc +1 more source

